Wolverine Trading, LLC Ginkgo Bioworks Holdings, Inc. Call Options Transaction History

Wolverine Trading, LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$0.28 - $1.16 $61,768 - $255,895	220,600 New	220,600 $72,000
Q4 2023 Feb 14, 2024	SELL	$1.26 - $1.79 $20,160 - $28,640	-16,000 Reduced 6.46%	231,600 $391,000
Q3 2023 Nov 15, 2023	BUY	$1.61 - $2.54 $81,144 - $128,016	50,400 Added 25.56%	247,600 $448,000
Q2 2023 Aug 23, 2023	SELL	$1.14 - $1.95 $1,937 - $3,315	-1,700 Reduced 0.85%	197,200 $366,000
Q1 2023 May 15, 2023	SELL	$1.2 - $2.19 $99,960 - $182,427	-83,300 Reduced 29.52%	198,900 $245,000
Q4 2022 Feb 14, 2023	BUY	$1.63 - $3.52 $169,031 - $365,024	103,700 Added 58.1%	282,200 $477,000
Q3 2022 Nov 14, 2022	SELL	$0.73 - $3.74 $1,679 - $8,602	-2,300 Reduced 1.27%	178,500 $559,000
Q2 2022 Aug 15, 2022	BUY	$2.2 - $4.2 $397,760 - $759,360	180,800 New	180,800 $452,000
Q1 2022 May 16, 2022	SELL	$2.83 - $8.69 $407,237 - $1.25 Million	-143,900 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$8.31 - $14.92 $370,626 - $665,432	44,600 Added 44.91%	143,900 $1.29 Million
Q3 2021 Nov 12, 2021	BUY	$9.15 - $13.28 $908,595 - $1.32 Million	99,300 New	99,300 $1.21 Million

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $11.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.